Headline Roundup December 23, 2020

US Buys 100 Million More Doses of Pfizer Coronavirus Vaccine

Coronavirus,Coronavirus Vaccine,Pfizer,Department Of Health And Human Services,Safety And Sanity During COVID-19

Summary from the AllSides News Team

Pfizer announced Wednesday that the Trump administration had reached a $1.95 billion agreement with the company to buy 100 million more doses of the double-dose Pfizer-BioNTech COVID-19 vaccine. Pfizer is expected to deliver 70 million of these doses by June 2021 and the remaining 30 million doses by the end of July. The agreement brings the total number of Pfizer vaccine doses bought by the U.S. to 200 million, or enough to vaccinate 100 million people. The deal also includes an option for the U.S. to buy another 400 million doses. Coverage was mostly balanced across bias ratings, with more original coverage published in center- and left-rated outlets. Some coverage discussed concerns over Pfizer’s manufacturing capacity.

Featured Coverage of this Story

U.S. buys another 100 million doses of Pfizer vaccine

Axios

See rating details

U.S. buys another 100 million doses of Pfizer vaccine

Axios

News

The Trump administration has reached an agreement with Pfizer and BioNTech to purchase 100 million additional doses of their coronavirus vaccine, which will be fully delivered no later July 31, 2021, the Department of Health and Human Services announced Wednesday.

Why it matters: The deal will allow millions more Americans to be vaccinated at zero cost by next fall. Under the terms of the agreement, 70 million of the 100 million doses purchased will be delivered by June 30, 2021.

The big picture: 200 million Pfizer doses — enough to...

Open on Axios

Trump Administration Announces Purchase Of 100 Million Additional Doses Of Pfizer Coronavirus Vaccine

The Daily Caller

See rating details

Trump Administration Announces Purchase Of 100 Million Additional Doses Of Pfizer Coronavirus Vaccine

The Daily Caller

News

The Trump Administration has purchased an additional 100 million doses of Pfizer’s coronavirus vaccine, the drugmaker announced Wednesday.

The new agreement means that Pfizer will supply 200 million doses to the United States, according to the company’s statement, which will be distributed through July 2021. Also included in the deal is the option to purchase an additional 400 million doses.

“With these 100 million additional doses, the United States will be able to protect more individuals and hopefully end this devastating pandemic more quickly,” said Pfizer CEO Albert Bourla. “We...

Open on The Daily Caller

U.S. buys another 100M doses of Pfizer-BioNTech coronavirus vaccine

Politico

See rating details

U.S. buys another 100M doses of Pfizer-BioNTech coronavirus vaccine

Politico

News

Pfizer and its German partner BioNTech will supply 100 million more doses of their coronavirus vaccine to the United States by this summer after protracted negotiations over how much the companies could deliver, given their commitments to other nations.

The $1.95 billion agreement doubles the overall U.S. order for the vaccine to 200 million doses. Pfizer and BioNTech said they can supply 70 million doses by June 30, 2021, with the remaining 30 million doses delivered by the end of July.

Open on Politico

More headline roundups